Table 4.
The mean and standard deviation of Malondialdehyde (MDA)in different concentrations of silver nanoparticles, graphene and silver-graphene nanocomposites on the MCF-7 breast cancer cell
| Control | cisplatin | 15 | 30 | 60 | 120 | 250 | ||
|---|---|---|---|---|---|---|---|---|
| silver nanoparticles | Mean | 4.400 | 58.00 | 33.40 | 40.20 | 50.40 | 55.40 | 68.00 |
| Std. Deviation | 2.302 | 1.581 | 2.966 | 2.588 | 2.702 | 2.702 | 2.345 | |
| graphene | Mean | 4.400 | 58.00 | 31.80 | 44.20 | 53.00 | 57.20 | 65.20 |
| Std. Deviation | 2.302 | 1.581 | 1.789 | 1.924 | 2.236 | 4.207 | 3.114 | |
| silver-graphene nanocomposites | Mean | 4.400 | 58.00 | 26.00 | 36.40 | 45.80 | 55.60 | 74.40 |
| Std. Deviation | 2.302 | 1.581 | 4.062 | 3.578 | 3.834 | 3.050 | 3.647 |